Evidence map›Paper›PMID 39118794›Full record

ArticleIranian journal of pathology2024

Strategic Framework for Strengthening Health Laboratory Services in the COVID-19 Pandemic in Iran.

Nooshafarin Safadel, Parisa Dahim, Siamak Mirab Samiee, Katayoon Khodaverdian, Maryam Mir Mohammad Ali Roodaki, Soghra Anjarani, Shahla Farsi, Mahdi Rafiee, Marjan R Farzami

Abstract read
In one paragraph

Article in Iranian journal of pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nooshafarin SafadelReference Health Laboratory of Iran, Ministry of Health and Medical Education, Tehran, Iran.
Parisa DahimReference Health Laboratory of Iran, Ministry of Health and Medical Education, Tehran, Iran.
Siamak Mirab SamieeCardiogenetic Research Center, Rajaie Cardiovascular Medical and Research Institute, Tehran, Iran.
Katayoon KhodaverdianReference Health Laboratory of Iran, Ministry of Health and Medical Education, Tehran, Iran.
Maryam Mir Mohammad Ali RoodakiReference Health Laboratory of Iran, Ministry of Health and Medical Education, Tehran, Iran.
Soghra AnjaraniReference Health Laboratory of Iran, Ministry of Health and Medical Education, Tehran, Iran.
Shahla FarsiReference Health Laboratory of Iran, Ministry of Health and Medical Education, Tehran, Iran.
Mahdi RafieeReference Health Laboratory of Iran, Ministry of Health and Medical Education, Tehran, Iran.
Marjan R FarzamiReference Health Laboratory of Iran, Ministry of Health and Medical Education, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Objective: Providing equitable access to good quality, timely, and affordable laboratory testing has always been a top priority for the Ministry of Health and Medical Education (MoH-ME) and the Reference Health Laboratory (RHL). Considering the significant role of medical laboratories in disease surveillance, RHL developed a strategic plan to manage laboratory services during the COVID-19 pandemic based on the "Strategic Framework for strengthening health laboratory services, 2016-2020" proposed by the World Health Organization (WHO). This article describes the steps taken to establish the strategic framework in Iran. Methods: Firstly, a National Laboratory Committee was formed in MoH-ME and a situation analysis was conducted to explore the strengths, weaknesses, opportunities, and threats in different components of our laboratory system. Gaps and resources needed to address those gaps were determined; then, RHL outlined operational processes and mechanisms for monitoring the activities. Results: The WHO strategic roadmap and its six strategic goals concerning leadership, quality, human resources, safety and security, laboratory networking, and rational use of laboratory testing, helped us to promote national laboratory services in accordance with health system requirements in the COVID-19 pandemic. Conclusion: The establishment of a national molecular laboratory network with more than 500 laboratories from different sectors may result in timely access to countrywide laboratory services and would be beneficial for future COVID-19 and/or other viral outbreaks. Continual evaluation of the COVID-19 laboratories' performance, production of PCR test kits by the local manufacturers, and development of a platform for virtual training would be other accomplishments that Iran achieved in coping with the recent pandemic.

Indexed as

Clinical laboratory servicesCOVID-19 nucleic acid testingCOVID-19 pandemicLaboratory diagnosesSARS-CoV-2 infectionStrategic planning

Identifiers

PMID39118794
PMCPMC11304460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.